hoe 166 has been researched along with k-strophanthin-beta in 1 studies
Studies (hoe 166) | Trials (hoe 166) | Recent Studies (post-2010) (hoe 166) | Studies (k-strophanthin-beta) | Trials (k-strophanthin-beta) | Recent Studies (post-2010) (k-strophanthin-beta) |
---|---|---|---|---|---|
6 | 0 | 0 | 128 | 1 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, R; Glossmann, H; Grabner, M; Henning, R; Kaiser, J; Knaus, HG; Linz, W; Meusburger, E; Schölkens, B; Striessnig, J | 1 |
1 other study(ies) available for hoe 166 and k-strophanthin-beta
Article | Year |
---|---|
Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.
Topics: Action Potentials; Animals; Binding, Competitive; Calcium Channel Blockers; Calcium Channels; Guinea Pigs; Heart; Hippocampus; In Vitro Techniques; Isradipine; Muscle Contraction; Muscle, Smooth; Muscles; Myocardial Contraction; Myocardium; Oxadiazoles; Papillary Muscles; Piperidines; Rabbits; Receptors, Nicotinic; Splanchnic Circulation; Strophanthins; Thiazines | 1988 |